Russia’s Cancer Vaccine Enteromix Displays 100 Per Cent Efficacy In Clinical Trials

Russia’s Cancer Vaccine Enteromix Displays 100 Per Cent Efficacy In Clinical Trials

Last Updated:September 06, 2025, 23:11 is Enteromix, a personalized mRNA cancer vaccine, showed 100% efficacy and safety in trials. Developed by Russian institutes, it awaits Ministry of Health approval for public use. With trials completed successfully, the only remaining step is regulatory clearance. (AI-generated pic) In what could be a ground-breaking achievement in the fight…

Read More
Russia Develops New MRNA Cancer Vaccine, Set For Free Distribution By 2025

Russia Develops New MRNA Cancer Vaccine, Set For Free Distribution By 2025

In a significant advancement, Russia has developed an mRNA-based vaccine targeting cancer, according to reports from the national news agency TASS. The vaccine is slated to be available to patients at no cost by 2025. Collaborative Effort and Development Andrey Kaprin, General Director of the Radiology Medical Research Centre under the Russian Ministry of Health,…

Read More